Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years

24 Jun 2005

Abstract excerpt

BACKGROUND: In patients with glioblastoma, age < 50 years was identified as a consistent prognostic variable. In addition, the prognosis for these patients may be determined by a complex interaction between age and genetic alterations. The objective of the current study was the molecular analysis of glioblastomas from adult patients age < 50 years ("young adults"). METHODS: The authors analyzed a set of 189...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Glioma Diagnosis and Treatment
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15981281
DOI: 10.1002/cncr.21221

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 yearsPMID 15981281Read ↗

Age-dependent prognostic effects of genetic alterations in glioblastoma.Semantic proximity Read ↗

Genetic markers in glioblastoma: prognostic significance and future therapeutic implications.Semantic proximity Read ↗

Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.Semantic proximity Read ↗

Prognostic impact of molecular markers in a series of 220 primary glioblastomasSemantic proximity Read ↗

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.Semantic proximity Read ↗

Impact of genotype and morphology on the prognosis of glioblastoma.Semantic proximity Read ↗

Homozygous 10q23/ PTEN deletion and its impact on outcome in glioblastoma: A prospective translational study on a uniformly treated cohort of adult patientsSemantic proximity Read ↗

Glioblastomas in the Older OldSemantic proximity Read ↗

Pediatric Oligodendrogliomas: A Study of Molecular Alterations on 1p and 19q Using Fluorescence In Situ HybridizationSemantic proximity Read ↗

Patients with High-Grade Gliomas Harboring Deletions of Chromosomes 9p and 10q Benefit from Temozolomide TreatmentSemantic proximity Read ↗

Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trialsSemantic proximity Read ↗

Chromosomal abnormalities in human glioblastomas: Gain in chromosome 7p correlating with loss in chromosome 10qSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.